| 1 |
Pharmacological options for the management of refractory cancer pain—what is the evidence? |
|
| | B. Afsharimani,K. Kindl,P. Good,J. Hardy | | | Supportive Care in Cancer. 2015; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Tramadol reduces anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats |
|
| | Ombretta Caspani,Marie-Céline Reitz,Angelo Ceci,Andreas Kremer,Rolf-Detlef Treede | | | Pharmacology Biochemistry and Behavior. 2014; 124: 290 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements? |
|
| | Shivani Shinde,Pamela Gordon,Prashant Sharma,James Gross,Mellar P. Davis | | | Supportive Care in Cancer. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Endogenous opiates and behavior: 2013 |
|
| | Richard J. Bodnar | | | Peptides. 2014; | | | [Pubmed] [Google Scholar] [DOI] | |
|
